Across TCGA patient cohorts, MYBPHL mutation is significantly associated with the RNA expression of many other genes, with 94 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MYBPHL-associated genes across cancer lineages are MIR367, MORF4L1P7, and LINC01851. Each is linked with MYBPHL in more than 1 cancer types. Because this analysis shows association rather than direction, both MYBPHL-to-partner and partner-to-MYBPHL results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MYBPHL→partner) and Y-score (partner→MYBPHL) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	MIR367 →	+0.681	+2.783	<.001	.008	3	2
UCEC	MORF4L1P7 →	+0.064	+4.069	.005	.008	3	2
CESC	LINC01851 →	+0.068	+5.418	<.001	.005	3	1
CESC	RN7SL303P →	+0.265	+5.201	<.001	.007	3	1
CESC	RPL34P17 →	+0.125	+5.539	<.001	.004	3	1
CESC	MIR4311 →	+0.348	+6.144	.001	.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 94 associations by consensus.

Exploration

MYBPHL survival (RNA) · tumor vs normal (RNA) · all MYBPHL data types